ADELINA MATATOVA: Open Payments
NPI 1316427479 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,121 in 101 payments from 20 companies in 2025. Trend: 2023 $1,878 · 2024 $2,234 · 2025 $2,121
Food & beverage: $2,041Education: $81
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 8 | $395 |
| ABBVIE INC. | 18 | $320 |
| GENZYME CORPORATION | 7 | $218 |
| Incyte Corporation | 10 | $187 |
| Galderma Laboratories, L.P. | 13 | $181 |
| Novartis Pharmaceuticals Corporation | 5 | $152 |
| LEO Pharma Inc. | 5 | $101 |
| Organon LLC | 10 | $95 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $92 |
| UCB, Inc. | 2 | $69 |
Products named: DUPIXENT, SKYRIZI, OPZELURA, COSENTYX, RINVOQ, VTAMA, ADBRY, AKLIEF.
Industry payments across AZ — which companies pay providers there.
